In this Alert, we discuss the proposed legislation and provide a comparison to the UK and California modern slavery reporting requirements.

In a new advisory opinion, the U.S. Department of Health and Human Services Office of Inspector General clarified the scope of the Anti-Kickback Statute warranty safe harbor.

On September 13, 2017, President Donald Trump issued an Executive Order blocking investment firm, Canyon Bridge Capital Partners Inc., from acquiring Lattice Semiconductor Corporation.

Controlling stockholder buyouts of Delaware corporations are generally scrutinized under the lens of "entire fairness" to determine whether the transaction was the product of fair dealing and fair price.

On 5 September 2017, in the case of Bărbulescu v Romania (Application no. 61496/08), the Grand Chamber of the European Court of Human Rights reversed a First Chamber decision and found that the Romanian courts, ...

The Board of Governors of the Federal Reserve System has adopted final rules that represent a significant shift in the terms of over-the-counter derivatives, repurchase and reverse repurchase transactions...

In Oil States, the "trial argument" is made to distinguish IPR proceedings from patent reexamination.

On July 27 of this year, Andrew Bailey, chief executive of the FCA, delivered a speech in which he questioned the sustainability of LIBOR in its current form.

PTAB Expanded Panels Impact Less Than 1% of All AIA Trials

An objection operates to preserve errors in admitting evidence. At the PTAB, the manner and timing of making evidentiary objections is governed by agency rule rather than the Federal Rules of Evidence (FRE).

Article III Standing Only Necessary for Party Invoking Authority of Federal Courts

In China, medical devices are divided into three regulatory classes based on the identified risks associated with the devices.

Having found that hiQ's claims were not preempted under the CFAA, the court then went on to address the potential merits of hiQ's claims under state law.

In the world of fee-for-service health care, most medical devices were sold to hospitals or other health care providers for use in the diagnosis or treatment of patients.

Every so often a decision comes out of the USPTO's Patent Trial & Appeal Board (PTAB) or the Federal Circuit that has immediate value for patent prosecutors.